About us Mō mātou

About the Ministry of Health and the New Zealand health system. 

Regulation & legislation Ngā here me ngā ture

Health providers and products we regulate, and laws we administer.

Strategies & initiatives He rautaki, he tūmahi hou

How we’re working to improve health outcomes for all New Zealanders.

Māori health Hauora Māori

Increasing access to health services, achieving equity and improving outcomes for Māori.

Statistics & research He tatauranga, he rangahau

Data and insights from our health surveys, research and monitoring.

On this page

End of Life Review Committee

The End of Life Review Committee considers assisted death reports under the End of Life Choice Act 2019. The Act allows people experiencing unbearable suffering from a terminal illness to ask for medical assistance to end their life.

End of Life Review Committee

Health Workforce and System Efficiencies Committee

The Health Workforce and System Efficiencies Committee works on systems and strategies to ensure New Zealand’s health workforce meets the needs of people, whānau and communities now and in the future.

It was established under section 87 of the Pae Ora (Healthy Futures) Act 2022.

Medsafe committees

Medicines Adverse Reactions Committee

The Medicines Adverse Reactions Committee advises the Minister of Health on the safety of approved medicines.

Medicines Adverse Reactions Committee

Medicines Assessment Advisory Committee

The Medicines Assessment Advisory Committee advises the Minister of Health on the benefits and risks of new medicines.

Medicines Assessment Advisory Committee

Medicines Classification Committee

The Medicines Classification Committee makes recommendations to the Minister of Health on the classifications of medicines.

Medicines Classification Committee

Medicines Review Committee

The Medicines Review Committee makes inquiries into any objection to the terms of a recommendation made under section 22(2) of the Medicines Act 1981. It reports its findings to the Minister of Health and hears appeals under section 88 of the Act.

Medicines Review Committee

National Cervical Screening Programme Review Committee

A review committee is established at least every 3 years to review the operation of the National Cervical Screening Programme under Part 4A, section 112O of the Health Act 1956.

The focus of the committee is the continuous quality improvement of components of the National Cervical Screening Programme. This is to reduce the incidence and mortality rates of cervical cancer.

National Cervical Screening Programme Report 2021

National Kaitiaki Group

The National Kaitiaki Group ensures protection of Māori women’s cervical screening data under the Health (Cervical Screening (Kaitiaki)) Regulations 1995.

National Kaitiaki Group – Health New Zealand

Psychoactive Substances Appeals Committee

The Psychoactive Substances Appeals Committee is established under the Psychoactive Substances Act 2013. The committee hears appeals against decisions made by the Psychoactive Substances Regulatory Authority.

Psychoactive Substances Appeals Committee

Psychoactive Substances Expert Advisory Committee

The Psychoactive Substances Expert Advisory Committee is established under the Psychoactive Substances Act 2013. The Committee provides expert advice to the Psychoactive Substances Regulatory Authority about safety issues with proposed psychoactive products.

Psychoactive Substances Expert Advisory Committee

Radiation Safety Advisory Council

The Radiation Safety Advisory Council advises the Minister of Health and Director for Radiation Safety on policies, codes of practice and recommendations for radiation safety standards.

It was established under section 80 of the Radiation Safety Act 2016.

Radiation Safety Advisory Council

Regulated Products Appeals Committee

The Regulated Products Appeals Committee determines appeals against decisions of the Director-General of Health to cancel or suspend a product notification for a vaping or smokeless tobacco product.

It was established under section 79 of the Smokefree Environments and Regulated Products Act 1990

In this section Kei tēnei wāhanga

  • Health and Disability System Review

    The Health and Disability System Review recommended changes to the health and disability system to meet the future needs of all New Zealanders

    More
  • Pharmac Review

    The Pharmac Review was established in 2021 to review the Pharmaceutical Management Agency (Pharmac). It released its final report in 2022.

    More
  • Ministerial Advisory Committee on Health Reform Implementation

    The Ministerial Advisory Committee on Health Reform Implementation advised on progress setting up the new health system under the Pae Ora (Healthy Futures) Act 2022. 

    More
  • Expert Advisory Committee on Drugs

    The Expert Advisory Committee on Drugs (EACD) provides expert advice to the Minister of Health on drug classification issues.

    More
Last updated
Last updated

© Ministry of Health – Manatū Hauora